Eledon Pharmaceuticals to Release Fourth Quarter and Full-Year Financial Results on Tuesday, March 30
23 mars 2021 08h00 HE
|
Eledon Pharmaceuticals, Inc.
IRVINE, Calif., March 23, 2021 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals (“Eledon”) (NASDAQ: ELDN), a clinical stage biopharmaceutical company focused on developing life-changing, targeted...
Eledon Pharmaceuticals Strengthens Leadership Team with Chief Medical Officer and Chief Financial Officer Hires
15 mars 2021 08h00 HE
|
Eledon Pharmaceuticals, Inc.
IRVINE, Calif., March 15, 2021 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), a clinical stage biopharmaceutical company focused on developing life-changing, targeted...
Eledon Pharmaceuticals to Present at H.C. Wainwright Global Life Sciences Conference
02 mars 2021 08h00 HE
|
Eledon Pharmaceuticals, Inc.
IRVINE, Calif., March 02, 2021 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), a clinical stage biopharmaceutical company focused on developing life-changing, targeted...
Eledon Pharmaceuticals to Present at 10th Annual SVB Leerink Global Healthcare Conference
17 févr. 2021 08h00 HE
|
Eledon Pharmaceuticals, Inc.
IRVINE, Calif., Feb. 17, 2021 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), a clinical stage biopharmaceutical company focused on developing life-changing, targeted...
Eledon Pharmaceuticals to Participate in the Virtual Noble Capital Markets' Seventeenth Annual Investor / Equity Conference
19 janv. 2021 17h55 HE
|
Eledon Pharmaceuticals, Inc.
IRVINE, Calif., Jan. 19, 2021 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), a clinical stage biopharmaceutical company focused on developing life-changing, targeted...
Novus Therapeutics Announces Name Change to Eledon Pharmaceuticals; Provides Corporate Update and Outlook
04 janv. 2021 08h00 HE
|
Novus Therapeutics, Inc.
Eledon to commence trading on the Nasdaq exchange under the ticker “ELDN” effective tomorrow, January 5, 2021 Eledon is well financed to complete up to four Phase 2 clinical trials of lead candidate...
Novus Therapeutics Announces Results of Special Meeting of Stockholders
22 déc. 2020 08h00 HE
|
Novus Therapeutics, Inc.
IRVINE, Calif., Dec. 22, 2020 (GLOBE NEWSWIRE) -- Novus Therapeutics, Inc. (“Novus”) (NASDAQ: NVUS), a clinical stage biopharmaceutical company focused on developing life-changing, targeted...